Company & Sponsor Intelligence
Beth Israel Deaconess Medical Center
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials8
Recruiting2
Completed5
Countries1
Therapeutic footprint
epilepsyneuromuscularother_neurologyout_of_scopeparkinsons
Indexed studies
NCT02118805Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
parkinsons · United StatesCOMPLETED
parkinsons · United StatesCOMPLETED
NCT03377543Sleep and Inflammatory Resolution Pathway
out_of_scope · United StatesEARLY_PHASE1
out_of_scope · United StatesEARLY_PHASE1
NCT07145489Infrared Photobiomodulation in Humans With Epilepsy
epilepsy · United StatesNA
epilepsy · United StatesNA
NCT00296413A Study to Look at Antiepileptic Drug Levels While on Lamictal or Depakote With or Without an Oral Contraceptive
epilepsy · United StatesCOMPLETED
epilepsy · United StatesCOMPLETED
NCT00029536Progesterone vs Placebo Therapy for Women With Epilepsy
epilepsy · United StatesPHASE3
epilepsy · United StatesPHASE3
NCT05883332A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters
other_neurology · United StatesPHASE4
other_neurology · United StatesPHASE4
NCT05238038Electrical Impedance Tomography for the Assessment of Neurological Disease
neuromuscular · United StatesCOMPLETED
neuromuscular · United StatesCOMPLETED
NCT01565395Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
parkinsons · United StatesPHASE2
parkinsons · United StatesPHASE2
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →